FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula in which R1 means hydrogen or alkyl with 1-4 carbon atoms, R2 means hydrogen and L means an alkandiyl group with 1-4 carbon atoms, one CH2-group in which can be substituted by with oxygen atom or a group of formula: or in which * means a conjunction with nitrogen atom, R3 means hydrogen, methyl, propane-2-yl, propane-1-yl, imidazol-4-ylmethyl, hydroxymethryl or 4-aminobutan-4-yl, or R3 is connected with R1 together with which forms (CH2)3- or (CH2)4- -group, R4 means hydrogen or methyl, R5 means alkyl with 1-4 carbon atoms, and R6 means hydrogen or alkyl with 1-4 carbon atoms, and also to its salt and to a method of preparing it.
EFFECT: there are prepared new compounds which can find application in medicine for treating and/or preventing diseases, first of all thromboembolic diseases.
5 cl, 4 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
AMINOACYL DERIVATIVES AS PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2456283C9 |
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
DIPEPTIDE PRODRUGS AND USE THEREOF | 2008 |
|
RU2486183C9 |
HETEROCYCLYLAMIDOSUBSTITUTED IMIDAZOLE DERIVATIVES | 2006 |
|
RU2415851C2 |
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
SULPHONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | 2012 |
|
RU2606639C2 |
DIPEPTIDE PRODRUG, ITS APPLICATION AND MEDICINE | 2013 |
|
RU2629558C2 |
BENZIMIDAZOLE DERIVATIVES | 2020 |
|
RU2803284C1 |
SUBSTITUTED ARYLSULFONAMIDES AS ANTIVIRAL AGENTS | 2007 |
|
RU2423352C2 |
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
Authors
Dates
2011-12-10—Published
2007-02-06—Filed